HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Immunotherapy of severe gram-negative bacterial infections. Centoxin: a new drug under monitoring. National Committee for the Evaluation of Centoxin].

Authors
JournalPathologie-biologie (Pathol Biol (Paris)) Vol. 40 Issue 10 Pg. 975-6 (Dec 1992) ISSN: 0369-8114 [Print] France
Vernacular TitleImmunothérapie des infections graves à bacilles à gram négatif. Le centoxin: un médicament en liberté surveillée. Comité National d'Evaluation du Centoxin.
PMID1299810 (Publication Type: Journal Article)
Chemical References
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Endotoxins
  • nebacumab
Topics
  • Antibodies, Monoclonal (therapeutic use)
  • Antibodies, Monoclonal, Humanized
  • Bacteremia (microbiology, therapy)
  • Drug Evaluation
  • Endotoxins (therapeutic use)
  • Gram-Negative Bacterial Infections (therapy)
  • Humans
  • Immunotherapy
  • Monitoring, Physiologic

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: